Nucleome Therapeutics News and Activities

View the org chart displaying its 16 main executives

Most searched biographies at Nucleome Therapeutics

• Mark Bodmer, Chief Executive Officer
• Jim Hughes, Director
• Russell Greig, Non-Executive Director

Popular executive movements at Nucleome Therapeutics

• Michelle Morrow has joined the company as Chief Scientific Officer  (posted on February 17 2026).

Create your alert
to follow the executive moves at Nucleome Therapeutics.

Nucleome Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Nucleome Therapeutics

• V-domain Immunoglobulin Suppressor of T cell Activation (VISTA) acts as an activating ligand for monocytes and is upregulated in systemic lupus erythematosus – Nucleome
• News – Nucleome
• News – Nucleome
• News – Nucleome
• News – Nucleome
• News – High resolution genetic mapping has identified a novel disease target for rheumatoid arthritis - Nucleome
• News – Nucleome Therapeutics announces a strategic collaboration with Johnson & Johnson to map genetic associations linked to autoimmune disease - Nucleome
• News – Nucleome Therapeutics appoints Mark Bodmer as Chief Executive Officer - Nucleome
• News – Nucleome Therapeutics announces transition of leadership - Nucleome
• News – Nucleome Therapeutics establishes Scientific Advisory Board of world-leading experts and appoints Dr John Davis as Non-Executive Director of the Board - Nucleome
• View more press releases Close

Social media about Nucleome Therapeutics

• Nucleome Therapeutics on Wikipedia, Google News & Yahoo Finance
• Nucleome Therapeutics on LinkedIn, X (Twitter) & YouTube